Theme | Proposed quality indicators |
---|---|
Patient education | The site provides and delivers patient education materials in the preoperative period which cover expectations of perioperative pain and pain management options including the risks and benefits of opioids |
The site provides and delivers patient education materials at discharge which cover the provision of patient education on safe storage and disposal of unused opioids in the community, the requirement to avoid opioid diversion, and opioid specific discharge advice, e.g., DVLA requirements | |
Staff education | The site provides and delivers multi-professional education materials on opioid stewardship |
The site provides and delivers multi-professional education materials on the provision of multimodal analgesia at all stages of the patient journey starting in the preoperative setting | |
Percentage of prescribers who receive regular reports comparing their prescribing to hospital guidelines | |
The site provides and delivers educational materials on the need for a clear discharge pain management plan and tapering strategy | |
Preoperative patient optimization | The presence of a system to identify opioid tolerance preoperatively, defined as opioids used for 7Â days or fewer in the 60Â days prior to surgery. |
The provision of a specialist pain service and referral pathway to enable opioid weaning and patient-specific analgesic planning for preoperative optimization for patients with opioid tolerance | |
The site uses a preoperative screening tool to identify patients with risk factors for persistent postoperative opioid use (PPOU) | |
Patient and procedure-specific prescribing and deprescribing | The site has an acute pain service with the ability to provide a daily pain review |
The electronic record is used as a means to detect or highlight potentially inappropriate high-dose postoperative opioid prescriptions | |
Review takes place to evaluate the procedure-specific mean daily inpatient MME used | |
Use of higher dosage of opioids (> 50–60 MME per day) at any time during the perioperative journey is used as a flag for further review | |
The site has a perioperative analgesia protocol which includes regional blocks and multimodal analgesia | |
The presence of procedure-specific protocols for use of in-patient opioids specifically promoting the avoidance of long-acting opioids | |
The presence of a review postoperatively seeking new risk factors for PPOU identified including, e.g., formation of a stoma | |
The percentage of those who are still using opioids at 90–180 days postoperatively (where the denominator is patients undergoing major surgery for bowel cancer) | |
The use of protocolized opioid prescribing for hospital discharge: | |
The site has a system to guide prescribing | |
The site has a system to allow the review of the procedure-specific mean discharge opioids prescribed for a particular patient group | |
The site has a patient group-specific guideline or algorithm to guide discharge opioid prescribing | |
The electronic record is used to enable procedure-specific prescribing limits | |
Procedure-specific postoperative prescribing guidelines are used to provide enough doses at discharge to cover 75% of patients (where the denominator is all patients undergoing that procedure) | |
The site has a system in place to allow the discharge pain management plan and tapering strategy to be clearly communicated to primary care team in a timely manner The opioid requirement, e.g., total consumed during the 24Â h prior to discharge is used as a guide for opioids prescribed on discharge | |
The presence of a review process for opioid prescription at discharge, where the denominator is all patients discharged having had a major surgery for bowel cancer: | |
The frequency of any opioids prescribed on hospital discharge | |
The frequency of slow-release opioid prescription on discharge | |
The frequency of immediate-release opioid prescription on discharge | |
The frequency of non-opioid adjuvant analgesia prescription on discharge | |
The presence of a protocol to guide de-escalation plan for opioids prescribed on discharge | |
Protocolized use of the ‘reverse pain ladder’ to guide de-escalation | |
Pain management plan and tapering strategy clearly communicated to the primary care team in a timely manner | |
The presence of a process to assess opioids prescribed versus opioids actually used following surgical procedures to allow tailoring of opioid prescriptions to need for a patient group/specific procedure | |
The presence of patient screening for risk of PPOU at discharge | |
Follow up for patients at greatest risk of persistent postoperative opioid use | |
The presence of a system to detect new or repeat opioid prescriptions given within 30Â days of discharge | |
The presence of a protocol or clear plan to follow if opioid abuse or misuse is detected | |
Opioid-related adverse drug events (ORADEs) | The site uses a preoperative screening tool to identify patients at greatest risk of postoperative opioid-related adverse drug events (ORADEs). Documented risk factors are those who are male, obese, over 65, with comorbidities, a history of preoperative opioid use and those concurrently using sedative medication. |
The site has a system in place to detect ORADEs among postoperative inpatients | |
There is a system in place to detect ORADEs in the community setting following discharge |